ESTABLISHMENT LABS HOLDINGS (ESTA) Stock Fundamental Analysis
NASDAQ:ESTA • VGG312491084
79.67 USD
+4.71 (+6.28%)
At close: Feb 24, 2026
79.67 USD
0 (0%)
After Hours: 2/24/2026, 4:30:02 PM
We assign a fundamental rating of 3 out of 10 to ESTA. ESTA was compared to 185 industry peers in the Health Care Equipment & Supplies industry. ESTA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ESTA is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- ESTA had negative earnings in the past year.
- ESTA had a negative operating cash flow in the past year.
- In the past 5 years ESTA always reported negative net income.
- In the past 5 years ESTA always reported negative operating cash flow.
1.2 Ratios
- With a Return On Assets value of -24.62%, ESTA perfoms like the industry average, outperforming 48.11% of the companies in the same industry.
- Looking at the Return On Equity, with a value of -509.99%, ESTA is doing worse than 82.70% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -24.62% | ||
| ROE | -509.99% | ||
| ROIC | N/A |
ROA(3y)-29.75%
ROA(5y)-28.61%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Gross Margin, with a value of 68.74%, ESTA is in the better half of the industry, outperforming 76.22% of the companies in the same industry.
- In the last couple of years the Gross Margin of ESTA has remained more or less at the same level.
- The Profit Margin and Operating Margin are not available for ESTA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 68.74% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.71%
GM growth 5Y1.49%
2. Health
2.1 Basic Checks
- ESTA does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for ESTA has been increased compared to 1 year ago.
- The number of shares outstanding for ESTA has been increased compared to 5 years ago.
- The debt/assets ratio for ESTA has been reduced compared to a year ago.
2.2 Solvency
- An Altman-Z score of 2.65 indicates that ESTA is not a great score, but indicates only limited risk for bankruptcy at the moment.
- ESTA has a Altman-Z score of 2.65. This is in the better half of the industry: ESTA outperforms 67.03% of its industry peers.
- A Debt/Equity ratio of 15.06 is on the high side and indicates that ESTA has dependencies on debt financing.
- Looking at the Debt to Equity ratio, with a value of 15.06, ESTA is doing worse than 87.57% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 15.06 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.65 |
ROIC/WACCN/A
WACC9.75%
2.3 Liquidity
- ESTA has a Current Ratio of 3.33. This indicates that ESTA is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Current ratio, with a value of 3.33, ESTA is in the better half of the industry, outperforming 60.54% of the companies in the same industry.
- A Quick Ratio of 2.10 indicates that ESTA has no problem at all paying its short term obligations.
- With a Quick ratio value of 2.10, ESTA perfoms like the industry average, outperforming 56.76% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.33 | ||
| Quick Ratio | 2.1 |
3. Growth
3.1 Past
- The earnings per share for ESTA have decreased strongly by -10.08% in the last year.
- Looking at the last year, ESTA shows a very strong growth in Revenue. The Revenue has grown by 24.76%.
- ESTA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.13% yearly.
EPS 1Y (TTM)-10.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.59%
Revenue 1Y (TTM)24.76%
Revenue growth 3Y9.43%
Revenue growth 5Y13.13%
Sales Q2Q%33.7%
3.2 Future
- ESTA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.95% yearly.
- Based on estimates for the next years, ESTA will show a very strong growth in Revenue. The Revenue will grow by 26.34% on average per year.
EPS Next Y36.42%
EPS Next 2Y28.32%
EPS Next 3Y26.52%
EPS Next 5Y25.95%
Revenue Next Year26.54%
Revenue Next 2Y25.78%
Revenue Next 3Y26%
Revenue Next 5Y26.34%
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- ESTA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ESTA. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as ESTA's earnings are expected to grow with 26.52% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.32%
EPS Next 3Y26.52%
5. Dividend
5.1 Amount
- ESTA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
79.67
+4.71 (+6.28%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-05 2025-11-05/bmo
Earnings (Next)02-24 2026-02-24/bmo
Inst Owners105.4%
Inst Owner Change-2.89%
Ins Owners13.63%
Ins Owner Change0.2%
Market Cap2.32B
Revenue(TTM)190.97M
Net Income(TTM)-83.45M
Analysts82.86
Price Target84.92 (6.59%)
Short Float %17.14%
Short Ratio8.84
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)12.36%
Min EPS beat(2)-4.97%
Max EPS beat(2)29.69%
EPS beat(4)2
Avg EPS beat(4)-8.99%
Min EPS beat(4)-75.04%
Max EPS beat(4)29.69%
EPS beat(8)5
Avg EPS beat(8)-2.35%
EPS beat(12)8
Avg EPS beat(12)0.53%
EPS beat(16)9
Avg EPS beat(16)-21.43%
Revenue beat(2)1
Avg Revenue beat(2)-0.05%
Min Revenue beat(2)-1.47%
Max Revenue beat(2)1.38%
Revenue beat(4)1
Avg Revenue beat(4)-0.89%
Min Revenue beat(4)-2.16%
Max Revenue beat(4)1.38%
Revenue beat(8)3
Avg Revenue beat(8)-0.76%
Revenue beat(12)5
Avg Revenue beat(12)-1.06%
Revenue beat(16)8
Avg Revenue beat(16)-0.03%
PT rev (1m)0.44%
PT rev (3m)12.16%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.86%
EPS NY rev (1m)0.31%
EPS NY rev (3m)11.08%
Revenue NQ rev (1m)0.13%
Revenue NQ rev (3m)-0.1%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)0.69%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 12.12 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 141.49 | ||
| P/tB | 486.9 | ||
| EV/EBITDA | N/A |
EPS(TTM)-2.84
EYN/A
EPS(NY)-1.05
Fwd EYN/A
FCF(TTM)-2.71
FCFYN/A
OCF(TTM)-2.47
OCFYN/A
SpS6.57
BVpS0.56
TBVpS0.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -24.62% | ||
| ROE | -509.99% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 68.74% | ||
| FCFM | N/A |
ROA(3y)-29.75%
ROA(5y)-28.61%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.71%
GM growth 5Y1.49%
F-Score4
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 15.06 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 76.51% | ||
| Cap/Sales | 3.7% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.33 | ||
| Quick Ratio | 2.1 | ||
| Altman-Z | 2.65 |
F-Score4
WACC9.75%
ROIC/WACCN/A
Cap/Depr(3y)567.48%
Cap/Depr(5y)397.75%
Cap/Sales(3y)15.14%
Cap/Sales(5y)11.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.59%
EPS Next Y36.42%
EPS Next 2Y28.32%
EPS Next 3Y26.52%
EPS Next 5Y25.95%
Revenue 1Y (TTM)24.76%
Revenue growth 3Y9.43%
Revenue growth 5Y13.13%
Sales Q2Q%33.7%
Revenue Next Year26.54%
Revenue Next 2Y25.78%
Revenue Next 3Y26%
Revenue Next 5Y26.34%
EBIT growth 1Y-1.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year62.55%
EBIT Next 3Y44.22%
EBIT Next 5Y43.82%
FCF growth 1Y36.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y24.01%
OCF growth 3YN/A
OCF growth 5YN/A
ESTABLISHMENT LABS HOLDINGS / ESTA FAQ
What is the fundamental rating for ESTA stock?
ChartMill assigns a fundamental rating of 3 / 10 to ESTA.
What is the valuation status for ESTA stock?
ChartMill assigns a valuation rating of 1 / 10 to ESTABLISHMENT LABS HOLDINGS (ESTA). This can be considered as Overvalued.
How profitable is ESTABLISHMENT LABS HOLDINGS (ESTA) stock?
ESTABLISHMENT LABS HOLDINGS (ESTA) has a profitability rating of 1 / 10.
What is the expected EPS growth for ESTABLISHMENT LABS HOLDINGS (ESTA) stock?
The Earnings per Share (EPS) of ESTABLISHMENT LABS HOLDINGS (ESTA) is expected to grow by 36.42% in the next year.